HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 90/1/234    most recent ajcn.2009.27600v1 Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kenny, A. M Articles by Kerstetter, J. E Search for Related Content PubMed PubMed Citation Articles by Kenny, A. M Articles by Kerstetter, J. E Agricola Articles by Kenny, A. M Articles by Kerstetter, J. E

Soy proteins and isoflavones affect bone mineral density in older women: a randomized controlled trial^1,2,3

¹ From the Center on Aging, University of Connecticut Health Center, Farmington, CT (AMK, AK, SJW, and KMP); the Department of Allied Health Sciences, University of Connecticut, Storrs, CT (JEK, DEA, KMM, and RHA); and the Department of Nutritional Sciences, University of Connecticut, Storrs, CT (RSB).

² Supported by the USDA (CONR-2001-00630), the Donaghue Foundation (University of Connecticut Health Center GCRC no. 648), and grant no. M01RR006192 from the National Center for Research Resources, a component of the National Institutes of Health.

³ Address correspondence to JE Kerstetter, Department of Allied Health Sciences, 358 Mansfield Road, Box U-2101, University of Connecticut, Storrs, CT 06269-2101. E-mail: jane.kerstetter{at}uconn.edu.

Background: Soy foods contain several components (isoflavones and amino acids) that potentially affect bone. Few long-term, large clinical trials of soy as a means of improving bone mineral density (BMD) in late postmenopausal women have been conducted.

Objective: Our goal was to evaluate the long-term effect of dietary soy protein and/or soy isoflavone consumption on skeletal health in late postmenopausal women.

Design: We conducted a randomized, double-blind, placebo-controlled clinical trial in 131 healthy ambulatory women aged >60 y. Ninety-seven women completed the trial. After a 1-mo baseline period, subjects were randomly assigned into 1 of 4 intervention groups: soy protein (18 g) + isoflavone tablets (105 mg isoflavone aglycone equivalents), soy protein + placebo tablets, control protein + isoflavone tablets, and control protein + placebo tablets.

Results: Consumption of protein powder and isoflavone pills did not differ between groups, and compliance with the study powder and pills was 80–90%. No significant differences in BMD were observed between groups from baseline to 1 y after the intervention or in BMD change between equol and non-equol producers. However, there were significant negative correlations between total dietary protein (per kg) and markers of bone turnover (P < 0.05).

Conclusions: Because soy protein and isoflavones (either alone or together) did not affect BMD, they should not be considered as effective interventions for preserving skeletal health in older women. The negative correlation between dietary protein and bone turnover suggests that increasing protein intakes may suppress skeletal turnover. This trial was registered at clinicaltrials.gov as NCT00668447.